Skip to Content

BriaCell Therapeutics Corp BCTX Stock Quote

| Rating as of


Last close prices updated as of Jun 09, 2023, 3:59 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 6.21
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style Small Blend
  • Day Range 6.15  –  6.73
  • Year Range 4.23  –  8.37
  • Market Cap 99.2447 Mil
  • Volume / Avg 89,910.0 /  127,654.8
  • Price / Sales
  • Price / Book 10.69
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis BCTX

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics BCTX

Company Profile BCTX

Business Description

BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in advanced metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advanced-stage breast cancer by matching the patient’s HLA type.

235 - 15th Street, Suite 300, West Vancouver, 3rd Floor, Bellevue Centre
Vancouver, BC, V7T 2X1, CAN
Industry Biotechnology
Employees 12

Competitors & Peers BCTX

Morningstar does not cover competitors or peers for this firm.

FAQs for BriaCell Therapeutics Corp Stock

No. BCTX does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

BCTX’s market cap is 99.24 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

BCTX’s stock style is Small Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

BCTX’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare BCTX’s historical performance against its industry peers and the overall market.